ArticleApplied & translational genomics2015
The lifestylisation of healthcare? 'Consumer genomics' and mobile health as technologies for healthy lifestyle.
Article in Applied & translational genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Sharing behavior and health care utilization following direct-to-consumer genetic testing: a systematic review.Open research Europe · 2025Pooled it
- The role of interdisciplinary research team in the impact of health apps in health and computer science publications: a systematic review.Biomedical engineering online · 2016Pooled it
- Distinguishing social and medical traits: perspectives of scientists using polygenic scores.Journal of community genetics · 2026Article
- Public perceptions of biospecimen sampling and uncertainty in the context of personalised nutrition.PloS one · 2025Article
- Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study.Journal of medical Internet research · 2024Review
- The funhouse mirror: the I in personalised healthcare.Life sciences, society and policy · 2021Article
- The Limits of Empowerment: How to Reframe the Role of mHealth Tools in the Healthcare Ecosystem.Science and engineering ethics · 2020Article
- A mobile revolution for healthcare? Setting the agenda for bioethics.Journal of medical ethics · 2018Article
- Digital Medicine: An Opportunity to Revisit the Role of Bioethicists.The American journal of bioethics : AJOB · 2018Article
- "Bridge to the Literature"? Third-Party Genetic Interpretation Tools and the Views of Tool Developers.Journal of genetic counseling · 2018Article
- Direct to consumer genetic testing-law and policy concerns in Ireland.Irish journal of medical science · 2018Article
- Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.Journal of community genetics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Consumer genomics and mobile health provide health-related information to individuals and offer advice for lifestyle change. These 'technologies for healthy lifestyle' occupy an ambiguous space between the highly regulated medical domain and the less regulated consumer market. We argue that this ambiguity challenges implicit distinctions between what is medical and what is related to personal lifestyle choices within current regulatory systems. In this article, we discuss how consumer genomics and mobile health devices give rise to new ways of creating (and making sense of) health-related knowledge. We also address some of the implications of harnessing, rather than denying, the hybridity of mobile health devices, being situated between medical devices and consumer products, between health and lifestyle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.